Auf dieser Seite
PAVM PAVmed Inc. - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 13, 2026
$2,87
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$2,6152-Wochen-Tief
$28,4452-Wochen-Hoch
Marktkapitalisierung (MRQ)
$18M
P/E (TTM)
-0.3
EPS (TTM)
$-10.52
Umsatz (TTM)
$112.0K
Ihre Abzeichen
52W-Spanne
$3–$28
Analystenbewertung
BUY
Kursziel
$36
P/E
-0.3
ROE
-33.3%
Nettogewinnmarge
-10794.6%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
PAVM Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.87
Marktkapitalisierung (MRQ)
$18M
P/E (TTM)
-0.3
EPS (TTM)
$-10.52
Umsatz (TTM)
$112.0K
ROE (TTM)
-33.3%
52W-Spanne
$3–$28
PAVM Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 2. Januar 2026 | 1-for-30 | Umgekehrt |
| 7. Dezember 2023 | 1-for-15 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$71.0K2021-12-31 → 2025-12-31
EPS$-5.632022-12-31 → 2025-12-31
Freier Cashflow$-5M2020-12-31 → 2025-12-31
Nettogewinnmarge-10794.6%2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | PAVM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -0.35-Jahres-Durchschnitt ≈-0.5 | ≈-0.5 | · | · | |
| P/S (TTM) | 160.75-Jahres-Durchschnitt ≈1656.4 | ≈1656.4 | 2.1 | Überbewertet | |
| K/B (MRQ) | 0.55-Jahres-Durchschnitt ≈-4.4 | ≈-4.4 | 3.5 | Unterbewertet | |
| Kurs / FCF (TTM) | -2.35-Jahres-Durchschnitt ≈-17.4 | ≈-17.4 | · | · | |
| Kurs / Cashflow (TTM) | -2.35-Jahres-Durchschnitt ≈-18.0 | ≈-18.0 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 0.1 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | PAVM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -23841.1%5-Jahres-Durchschnitt ≈-13988.9% | ≈-13988.9% | -6.6% | Schwach | |
| EBITDA-Marge (TTM) | -23770.5%5-Jahres-Durchschnitt ≈-13797.5% | ≈-13797.5% | -4.6% | Schwach | |
| Vorgewinnmarge (TTM) | -14669.6%5-Jahres-Durchschnitt ≈-8861.9% | ≈-8861.9% | -11.8% | Schwach | |
| Nettogewinnmarge (TTM) | -10794.6%5-Jahres-Durchschnitt ≈-6869.6% | ≈-6869.6% | -12.2% | Schwach | |
| ROA (TTM) | -28.7%5-Jahres-Durchschnitt ≈-48.4% | ≈-48.4% | 1.1% | Im Einklang | |
| ROE (TTM) | -33.3%5-Jahres-Durchschnitt ≈-87.6% | ≈-87.6% | -103.4% | Spitzenklasse | |
| ROIC | -64.2% | · | -14.5% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | PAVM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 1.25-Jahres-Durchschnitt ≈0.4 | ≈0.4 | 1.4 | Geringe Liquidität | |
| Quick Ratio | 0.15-Jahres-Durchschnitt ≈0.4 | ≈0.4 | 0.8 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | PAVM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -97.6%5-Jahres-Durchschnitt ≈115.2% | ≈115.2% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -42.7% | · | · | · | |
| Net Income YoY (Nettogewinn YoY) | -99.0% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | PAVM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.0 | ≈0.0 | 0.9 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 4.35-Jahres-Durchschnitt ≈30.6 | ≈30.6 | 6.0 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$1.7K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-88.5%
Nächster Bericht
Nov 10, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 11, 2026 | $-0.87 | $-0.48 | -81.5% |
| 31. März 2026 | Mai 14, 2026 | $-4.42 | $-0.71 | -519.0% |
| 31. Dezember 2025 | $-5.52 | $-5.51 | -0.22% | |
| 30. September 2025 | $-8.70 | $-5.20 | -67.2% | |
| 30. Juni 2025 | $-22.20 | $-3.98 | -458.1% | |
| 31. März 2025 | $10.20 | $-3.98 | 356.4% | |
| 31. Dezember 2024 | $8.70 | $-17.44 | 149.9% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $71.0K | $3M | $2M | $377.0K | $500.0K | |
| Cost of Revenue | $218.0K | $5M | $6M | $4M | $585.0K | |
| Gross Profit | · | · | · | · | $-85.0K | |
| R&D Expense | $4M | $6M | $14M | $25M | $20M | |
| SG&A Expense | $16M | $25M | $31M | $41M | $25M | |
| Operating Expenses | $22M | $47M | $71M | $91M | $55M | |
| Operating Income | $-22M | $-44M | $-69M | $-91M | $-54M | |
| Interest Income | $29.0K | $254.0K | $505.0K | $169.0K | · | |
| Other Non-op | $19M | $73M | $-10M | $-12M | $-2M | |
| Pretax Income | $-2M | $28M | $-79M | $-103M | $-56M | |
| Income Tax | $0 | $0 | · | · | · | |
| Net Income | $401.0K | $40M | $-64M | $-89M | $-50M | |
| EPS (Basic) | $-5.63 | $99.15 | $-9.16 | $-15.03 | $-0.65 | |
| EPS (Diluted) | $-5.63 | $14.90 | $-9.16 | $-15.03 | · | |
| Shares (Basic) | 670,466 | 322,407 | 7,231,546 | 5,938,406 | 77,515,767 | |
| Shares (Diluted) | 670,466 | 2,173,398 | 7,231,546 | 5,938,406 | · | |
| EBITDA | $-22M | $-43M | $-66M | $-88M | $-54M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $1M | $20M | $40M | $77M | |
| Receivables | $15.0K | $18.0K | $61.0K | $17.0K | $200.0K | |
| Inventory | · | · | $278.0K | $111.0K | · | |
| Prepaid Expense | $1M | $961.0K | $5M | $4M | $5M | |
| Current Assets | $3M | $2M | $24M | $44M | $83M | |
| PP&E (Net) | $77.0K | $151.0K | $2M | $2M | $2M | |
| PP&E (Gross) | $1M | $1M | $4M | $3M | $2M | |
| Accum. Depreciation | $1M | $1M | $2M | $808.0K | $138.0K | |
| Intangibles | · | · | $1M | $3M | $2M | |
| Other Non-current Assets | $56.0K | $208.0K | $1M | $1M | $725.0K | |
| Total Assets | $39M | $31M | $33M | $54M | $87M | |
| Accounts Payable | $678.0K | $657.0K | $2M | $3M | $3M | |
| Accrued Liabilities | $2M | $5M | $7M | $4M | $4M | |
| Current Liabilities | $15M | $35M | $54M | $41M | $8M | |
| Capital Leases | $2M | $2M | $3M | $2M | · | |
| Total Liabilities | $17M | $38M | $57M | $43M | $8M | |
| Common Stock | $1.0K | $1.0K | $9.0K | $6.0K | $86.0K | |
| Paid-in Capital | $268M | $249M | $238M | $216M | $198M | |
| Retained Earnings | $-259M | $-255M | $-294M | $-228M | $-139M | |
| Treasury Stock | · | · | · | $408.0K | · | |
| Stockholders' Equity | $34M | $-2M | $-54M | $-10M | $62M | |
| Liabilities + Equity | $39M | $31M | $33M | $54M | $87M | |
| Shares Outstanding | 927,934 | 373,300 | 8,578,505 | 6,300,703 | 86,367,845 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $105.0K | $1M | $3M | $2M | $226.0K | |
| Stock-based Comp | $2M | $6M | $11M | $20M | $15M | |
| Amort. of Intangibles | $0 | $559.0K | $2M | $2M | $146.0K | |
| Other Non-cash | $-7M | $-81M | $-2M | $-4M | · | |
| Operating Cash Flow | $-5M | $-34M | $-52M | $-71M | $-41M | |
| CapEx | $31.0K | $55.0K | $242.0K | $2M | $1M | |
| Investing Cash Flow | $-31.0K | $-16M | $758.0K | $-5M | $-4M | |
| Stock Issued | · | $2M | $2M | $79.0K | $55M | |
| Net Stock Activity | · | $2M | $2M | · | $55M | |
| Financing Cash Flow | $6M | $31M | $31M | $38M | $104M | |
| Net Change in Cash | $353.0K | $-18M | $-20M | $-38M | $60M | |
| Taxes Paid | $0 | · | · | · | · | |
| Free Cash Flow | $-5M | $-34M | $-52M | $-73M | $-42M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | -17.0% | |
| Operating Margin | -30712.7% | -1482.9% | -2751.8% | -24118.6% | -10878.6% | |
| Net Margin | 564.8% | 1326.4% | -2567.0% | -23602.9% | -10069.4% | |
| Pretax Margin | -3477.5% | 947.6% | -3170.5% | -27384.1% | -11225.2% | |
| EBITDA Margin | -30564.8% | -1443.0% | -2634.5% | -23466.8% | -10878.6% | |
| ROA | 1.1% | 124.8% | -147.4% | -126.3% | -94.3% | |
| ROE | 2.2% | -141.3% | 202.1% | -342.3% | -158.4% | |
| ROIC | -64.2% | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 0.2 | 0.1 | 0.5 | 1.1 | · | |
| Quick Ratio | 0.1 | 0.0 | 0.4 | 1.0 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | 33.0 | · | · | |
| Receivables Turnover | 4.3 | 75.9 | 64.1 | 3.5 | 5.0 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $36.60 | $-0.22 | $-6.28 | $-0.10 | $0.71 | |
| Revenue / Share | $0.11 | $0.05 | $0.35 | · | · | |
| Cash Flow / Share | $-7.76 | $-0.51 | $-7.20 | · | · | |
| Cash / Share | $1.66 | $0.11 | $2.29 | $0.42 | $0.89 | |
| EPS (TTM) | $-5.63 | $14.90 | $-9.16 | $-15.03 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | -97.6% | 19.8% | 563.1% | -24.6% | · | |
| Revenue CAGR 3Y | -42.7% | 81.6% | · | · | · | |
| Net Income YoY | -99.0% | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $71.0K | $3M | $2M | $377.0K | $500.0K | |
| Net Income TTM | $401.0K | $40M | $-64M | $-89M | $-50M | |
| Market Cap | $6M | $7M | $35M | $680M | $3.19B | |
| P/E | -1.2 | 0.0 | -0.4 | -0.5 | · | |
| P/S | 86.7 | 2.3 | 14.1 | 1805.0 | 6373.9 | |
| P/B | 0.2 | -2.8 | -0.7 | -70.3 | 51.7 | |
| P / Tangible Book | 0.2 | · | · | · | 53.4 | |
| P / Cash Flow | -1.2 | -0.2 | -0.7 | -9.6 | -78.5 | |
| P / FCF | -1.2 | -0.2 | -0.7 | -9.4 | -75.8 | |
| Earnings Yield | -84.9% | 2372.6% | -222.3% | -208.8% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33.0K | $22.0K | $52.0K | $5.0K | $6.0K | $8.0K | $10.0K | $996.0K | $979.0K | $1M | · | $791.0K | $166.0K | $446.0K | · | $76.0K | |
| Cost of Revenue | $122.0K | $97.0K | $86.0K | $55.0K | $41.0K | $36.0K | $49.0K | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | |
| R&D Expense | $2M | $1M | $2M | $1M | $790.0K | $787.0K | $808.0K | $2M | $2M | $2M | $4M | $3M | $3M | $4M | $6M | $6M | |
| SG&A Expense | $5M | $6M | $5M | $4M | $4M | $4M | $4M | $7M | $7M | $7M | $7M | $7M | $7M | $10M | $10M | $10M | |
| Operating Expenses | $7M | $8M | $7M | $5M | $5M | $5M | $5M | $13M | $15M | $15M | $17M | $16M | $17M | $21M | $25M | $23M | |
| Operating Income | $-7M | $-8M | $-7M | $-5M | $-5M | $-5M | $-5M | $-12M | $-14M | $-14M | $-16M | $-16M | $-16M | $-20M | $-25M | $-23M | |
| Interest Expense | · | · | · | · | $26.0K | $26.0K | · | · | · | · | · | · | · | · | · | · | |
| Interest Income | $10.0K | $19.0K | $3.0K | $10.0K | $8.0K | $8.0K | $2.0K | $70.0K | $110.0K | $72.0K | $97.0K | $124.0K | $163.0K | $121.0K | $106.0K | $54.0K | |
| Other Non-op | $0 | $-40.0K | $4M | $-1M | $0 | $0 | $6M | $72M | $-1M | $-4M | $-1M | $-6M | $-1M | $-2M | $29.0K | $-7M | |
| Pretax Income | $-7M | $-1M | $-3M | $-6M | $-12M | $19M | $1M | $61M | $-15M | $-19M | $-17M | $-22M | $-18M | $-22M | $-25M | $-30M | |
| Income Tax | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-5M | $-60.0K | $-1M | $-5M | $-12M | $19M | $1M | $64M | $-11M | $-15M | $-14M | $-18M | $-15M | $-18M | $-20M | $-26M | |
| EPS (Basic) | $-0.87 | $-4.42 | $-5.88 | $-0.29 | $-22.08 | $38.26 | $96.53 | $6.43 | $-1.19 | $-2.62 | $-1.90 | $-2.38 | $-2.10 | $-2.78 | $-14.25 | $-0.29 | |
| EPS (Diluted) | $-0.87 | $-4.42 | $-4.94 | $-0.29 | $-22.08 | $10.10 | $17.27 | $1.44 | $-1.19 | $-2.62 | $-1.90 | $-2.38 | $-2.10 | $-2.78 | $-14.25 | $-0.29 | |
| Shares (Basic) | 6,269,384 | 1,580,788 | · | 21,554,546 | 602,822 | 462,539 | · | 10,005,379 | 9,152,819 | 8,694,904 | · | 7,462,751 | 6,956,655 | 6,473,010 | · | 89,758,927 | |
| Shares (Diluted) | 6,269,384 | 1,580,788 | · | 21,554,546 | 602,822 | 1,746,739 | · | 44,475,638 | 9,152,819 | 8,694,904 | · | 7,462,751 | 6,956,655 | 6,473,010 | · | 89,758,927 | |
| EBITDA | $-7M | $-8M | · | $-5M | $-5M | $-5M | · | $-12M | $-14M | $-13M | · | $-16M | $-16M | $-20M | · | $-23M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $6M | $2M | $3M | $4M | $3M | $1M | $765.0K | $25M | $26M | $20M | $26M | $37M | $49M | $40M | $57M | |
| Receivables | $16.0K | $21.0K | $15.0K | $3.0K | $3.0K | $9.0K | $18.0K | $16.0K | $219.0K | $67.0K | $61.0K | $36.0K | $41.0K | $27.0K | $17.0K | $31.0K | |
| Inventory | · | · | · | · | · | · | · | $6.0K | $687.0K | $410.0K | $278.0K | · | · | · | $111.0K | · | |
| Prepaid Expense | $1M | $933.0K | $1M | $1M | $1M | $929.0K | $961.0K | $1M | $4M | $4M | $5M | $6M | $6M | $5M | $4M | $5M | |
| Current Assets | $5M | $7M | $3M | $4M | $5M | $4M | $2M | $2M | $30M | $30M | $24M | $32M | $43M | $54M | $44M | $62M | |
| PP&E (Net) | $73.0K | $79.0K | $77.0K | $81.0K | $100.0K | $114.0K | $151.0K | $216.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $1M | · | · | · | $1M | · | · | · | $4M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $1M | · | · | · | $1M | · | · | · | $2M | · | · | · | $808.0K | · | |
| Intangibles | · | · | · | · | · | · | · | · | $947.0K | $1M | $1M | $2M | $2M | $3M | $3M | $4M | |
| Other Non-current Assets | $51.0K | $56.0K | $56.0K | $51.0K | $51.0K | $51.0K | $208.0K | $75.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Total Assets | $40M | $45M | $39M | $38M | $44M | $53M | $31M | $31M | $39M | $37M | $33M | $42M | $54M | $65M | $54M | $72M | |
| Accounts Payable | $1M | $983.0K | $678.0K | $342.0K | $387.0K | $369.0K | $657.0K | $465.0K | $1M | $1M | $2M | $2M | $1M | $1M | $3M | $2M | |
| Accrued Liabilities | $2M | $2M | $2M | $3M | $3M | $2M | $5M | $5M | $7M | $7M | $7M | $5M | $5M | $4M | $4M | $3M | |
| Current Liabilities | $4M | $4M | $15M | $10M | $11M | $10M | $35M | $38M | $53M | $55M | $54M | $55M | $51M | $51M | $41M | $42M | |
| Capital Leases | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $5M | $3M | $3M | $3M | $4M | $4M | $2M | $2M | |
| Total Liabilities | $21M | $20M | $17M | $12M | $12M | $12M | $38M | $40M | $58M | $58M | $57M | $58M | $55M | $54M | $43M | $44M | |
| Common Stock | $6.0K | $6.0K | $1.0K | $23.0K | $20.0K | $17.0K | $1.0K | $11.0K | $10.0K | $9.0K | $9.0K | $120.0K | $109.0K | $101.0K | $6.0K | $92.0K | |
| Paid-in Capital | $296M | $295M | $268M | $265M | $264M | $256M | $249M | $248M | $244M | $238M | $238M | $232M | $226M | $221M | $216M | $214M | |
| Retained Earnings | $-265M | $-259M | $-259M | $-257M | $-251M | $-237M | $-255M | $-256M | $-321M | $-310M | $-294M | $-279M | $-261M | $-246M | $-228M | $-208M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $408.0K | $408.0K | |
| Stockholders' Equity | $35M | $40M | $34M | $33M | $38M | $45M | $-2M | $-5M | $-74M | $-69M | $-54M | $-43M | $-32M | $-22M | $-10M | $9M | |
| Liabilities + Equity | $40M | $45M | $39M | $38M | $44M | $53M | $31M | $31M | $39M | $37M | $33M | $42M | $54M | $65M | $54M | $72M | |
| Shares Outstanding | 6,269,418 | 6,269,384 | 927,934 | 23,053,498 | 20,142,463 | 16,769,619 | 373,300 | 10,660,394 | 9,554,381 | 8,858,597 | 8,578,505 | 119,701,959 | 108,537,994 | 100,596,406 | 6,300,703 | 92,228,862 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $19.0K | $20.0K | $18.0K | $22.0K | $22.0K | $43.0K | $69.0K | $238.0K | $305.0K | $586.0K | $725.0K | $733.0K | $747.0K | $727.0K | $726.0K | $700.0K | |
| Stock-based Comp | $917.0K | $182.0K | $232.0K | $383.0K | $162.0K | $930.0K | $732.0K | $2M | $2M | $2M | $2M | $2M | $3M | $4M | $5M | $5M | |
| Amort. of Intangibles | · | · | · | · | · | · | $0 | $82.0K | $105.0K | $372.0K | $506.0K | $505.0K | $505.0K | $505.0K | $506.0K | $505.0K | |
| Other Non-cash | · | $-3M | · | · | · | $-22M | · | · | · | $-365.0K | · | · | · | $-4M | · | · | |
| Operating Cash Flow | $-3M | $-3M | $-2M | $-896.0K | $-1M | $-2M | $94.0K | $-9M | $-12M | $-13M | $-12M | $-11M | $-13M | $-16M | $-17M | $-19M | |
| CapEx | $13.0K | $22.0K | $14.0K | $3.0K | $8.0K | $6.0K | $4.0K | $6.0K | $3.0K | $42.0K | $183.0K | $18.0K | $15.0K | $26.0K | $298.0K | $316.0K | |
| Investing Cash Flow | $-13.0K | $-22.0K | $-14.0K | $-3.0K | $-8.0K | $-6.0K | $-4.0K | $-16M | $-3.0K | $-42.0K | $-183.0K | $-18.0K | $-15.0K | $974.0K | $-298.0K | $-1M | |
| Stock Issued | · | · | · | $0 | $0 | $841.0K | · | $284.0K | $198.0K | $786.0K | $367.0K | $0 | $609.0K | $557.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | $841.0K | · | · | · | $786.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $0 | $8M | $0 | $-2.0K | $2M | $3M | $330.0K | $284.0K | $12M | $19M | $5M | $352.0K | $684.0K | $25M | $80.0K | $12M | |
| Net Change in Cash | $-3M | $5M | $-2M | $-901.0K | $1M | $2M | $420.0K | $-25M | $-37.0K | $6M | $-7M | $-11M | $-12M | $10M | $-17M | $-8M | |
| Free Cash Flow | · | $-3M | · | · | · | $-2M | · | · | · | $-13M | · | · | · | $-16M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -21278.8% | -36522.7% | · | -96880.0% | -78583.3% | -68075.0% | · | -1157.8% | -1368.4% | -1403.6% | · | -1963.1% | -9930.1% | -4574.2% | · | · | |
| Net Margin | -16315.1% | -272.7% | · | -107660.0% | -198683.3% | 237100.0% | · | 6439.9% | -1082.7% | -1521.2% | · | -2234.0% | -8757.2% | -4020.4% | · | · | |
| Pretax Margin | -19993.9% | -4836.4% | · | -120220.0% | -205400.0% | 232787.5% | · | 6071.1% | -1491.4% | -1851.2% | · | -2749.7% | -10778.3% | -4980.7% | · | · | |
| EBITDA Margin | -21278.8% | -36431.8% | · | -96880.0% | -78583.3% | -67537.5% | · | -1157.8% | -1368.4% | -1345.0% | · | -1963.1% | -9930.1% | -4411.2% | · | · | |
| ROA | -12.8% | -0.12% | · | -15.7% | -28.6% | 42.1% | · | 177.5% | -23.3% | -29.7% | · | -30.9% | -21.4% | -24.0% | · | -45.3% | |
| ROE | -14.8% | -0.14% | · | -38.9% | 65.5% | -159.5% | · | -267.6% | 20.5% | 33.5% | · | 103.0% | 304.9% | -150.2% | · | -119.2% | |
| ROIC | -20.0% | -20.3% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 2.0 | · | 0.4 | 0.5 | 0.4 | · | 0.1 | 0.6 | 0.5 | · | 0.6 | 0.8 | 1.1 | · | 1.5 | |
| Quick Ratio | 0.9 | 1.8 | · | 0.3 | 0.4 | 0.3 | · | 0.0 | 0.5 | 0.5 | · | 0.5 | 0.7 | 1.0 | · | 1.4 | |
| Interest Coverage | · | · | · | · | -181.3 | -209.5 | · | · | · | · | · | · | · | · | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | · | · | · | · | · | · | · | 49.3 | 4.9 | 8.5 | · | · | · | · | · | · | |
| Receivables Turnover | 3.5 | 1.5 | · | 0.5 | 0.1 | 0.2 | · | 38.5 | 7.7 | 21.3 | · | 23.6 | 8.1 | 7.7 | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.59 | $6.30 | · | $1.41 | $1.86 | $2.68 | · | $-0.46 | $-7.74 | $-7.76 | · | $-0.36 | $-0.29 | $-0.22 | · | $0.10 | |
| Revenue / Share | $0.01 | $0.01 | · | $0.00 | $0.00 | $0.00 | · | $0.02 | $0.11 | $0.12 | · | $0.01 | $0.00 | · | · | · | |
| Cash Flow / Share | · | $-1.66 | · | · | · | $-0.03 | · | · | · | $-1.51 | · | · | · | · | · | · | |
| Cash / Share | $0.60 | $1.03 | · | $0.13 | $0.20 | $0.16 | · | $0.07 | $2.67 | $2.88 | · | $0.22 | $0.34 | $0.49 | · | $0.62 | |
| EPS (TTM) | $-10.52 | $-31.73 | · | $5.00 | $6.73 | $27.62 | · | $-4.27 | $-8.09 | $-9.00 | · | $-21.51 | $-19.42 | $-17.61 | · | · |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $112.0K | $85.0K | · | $29.0K | $1M | $2M | · | · | · | · | · | · | · | · | · | · | |
| Net Income TTM | $-12M | $-19M | · | $3M | $73M | $74M | · | $24M | $-58M | $-61M | · | $-71M | $-79M | $-90M | · | $-86M | |
| Market Cap | $37M | $64M | · | $10M | $12M | $12M | · | $13M | $8M | $19M | · | $530M | $664M | $564M | · | $1.19B | |
| P/E | -0.6 | -0.3 | · | 2.6 | 2.7 | 0.8 | · | -8.6 | -3.0 | -7.1 | · | -6.2 | -9.5 | -9.6 | · | · | |
| P/S | 332.5 | 748.6 | · | 10278.7 | 355.5 | 182.0 | · | · | · | · | · | · | · | · | · | · | |
| P/B | 1.1 | 1.6 | · | 0.3 | 0.3 | 0.3 | · | -2.7 | -0.1 | -0.3 | · | -12.2 | -21.1 | -25.6 | · | 133.0 | |
| P / Tangible Book | 1.1 | 1.6 | · | 0.3 | 0.3 | 0.3 | · | · | · | · | · | · | · | · | · | 238.0 | |
| P / Cash Flow | · | -24.3 | · | · | · | -7.6 | · | · | · | -1.4 | · | · | · | -34.7 | · | · | |
| Earnings Yield | -177.1% | -312.6% | · | 38.7% | 37.4% | 127.7% | · | -11.6% | -33.1% | -14.0% | · | -16.2% | -10.6% | -10.5% | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $71.0K | $3M | $2M | $377.0K | $500.0K |
| Bruttogewinnmarge % | · | · | · | · | -17.0% |
| Betriebsgewinnmarge % | -30712.7% | -1482.9% | -2751.8% | -24118.6% | -10878.6% |
| Nettoergebnis | $401.0K | $40M | $-64M | $-89M | $-50M |
| Verwässerte EPS | $-5.63 | $14.90 | $-9.16 | $-15.03 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 0.2 | 0.1 | 0.5 | 1.1 | · |
| Quick Ratio | 0.1 | 0.0 | 0.4 | 1.0 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-5M | $-34M | $-52M | $-73M | $-42M |
Institutionelle Eigentümer (13F) 23 Einreicher · $5.6M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
23
Gehaltener Wert
$5.6M
Neue Positionen
4
Geschlossene Positionen
5
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 4 (-14 vs. Vorquartal) | 5 (-7 vs. Vorquartal) | 6 (+6 vs. Vorquartal) | 3 (0 vs. Vorquartal) | +417K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Two Seas Capital LP | $2.741.542 | 461.539 | 48,64% | Aktien |
| FIRST MANHATTAN CO. LLC. | $1.977.491 | 332.911 | 35,08% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $365.928 | 61.604 | 6,49% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $217.871 | 36.678 | 3,87% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $152.094 | 25.605 | 2,70% | Aktien |
| BlackRock, Inc. | $101.526 | 17.092 | 1,80% | Aktien |
| VANGUARD GROUP INC | $75.620 | 342.171 | 1,34% | Aktien |
| CWM, LLC | $1.594 | 157 | 0,03% | Aktien |
| MORGAN STANLEY | $968 | 163 | 0,02% | Aktien |
| BARCLAYS PLC | $446 | 75 | 0,01% | Aktien |
| SBI Securities Co., Ltd. | $398 | 67 | 0,01% | Aktien |
| CIBC Private Wealth Group LLC | $360 | 836 | 0,01% | Aktien |
| UBS Group AG | $339 | 57 | 0,01% | Aktien |
| WELLS FARGO & COMPANY/MN | $267 | 45 | 0,00% | Aktien |
| Allworth Financial LP | $30 | 5 | 0,00% | Aktien |
| Binnacle Investments Inc | $29 | 67 | 0,00% | Aktien |
| Federation des caisses Desjardins du Quebec | $23 | 4 | 0,00% | Aktien |
| OSAIC HOLDINGS, INC. | $21 | 4 | 0,00% | Aktien |
| Steward Partners Investment Advisory, LLC | $12 | 2 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $6 | 1 | 0,00% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $6 | 1 | 0,00% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $5 | 1 | 0,00% | Aktien |
| ROYAL BANK OF CANADA | $0 | 1 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Aklog Lishan | 9. April 2026 | 5,10% | Erste Einreichung | Passive Anlage | SEC |
| Lishan Aklog, M.D., Pavilion Venture Partners LLC | 6. Juli 2018 | · | Erste Einreichung | Passive Anlage | SEC |
| Ira Scott Greenspan ×3 Einreichungen | 6. Juli 2018 | · | Erste Einreichung | · | SEC |
| Lishan Aklog, Pavilion Venture Partners LLC, HCFP/Capital Partners III LLC ×3 Einreichungen | 26. April 2018 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 19 Insider · 7 Führungskräfte · 10 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Aklog Lishan | Chairman and CEO | 2. April 2026 A | 357.614 | 0 | 0 | $0 |
| Dennis M Mcgrath | President and CFO | 2. April 2026 A | 186.695 | 0 | 0 | $0 |
| Richard F Fitzgerald | CFO and Secretary | 1. Juni 2016 A | 200 | 0 | 0 | $0 |
| Shaun O'Neil | Chief Operating Officer | 2. April 2026 A | 115.598 | 0 | 0 | $0 |
| Victoria Tou-Ho Lee | Chief Medical Officer | 2. April 2026 A | 71.666 | 0 | 0 | $0 |
| Michael Adam Gordon | General Counsel | 2. April 2026 A | 115.000 | 0 | 0 | $0 |
| Brian J. Deguzman | Chief Medical Officer | 18. Februar 2022 A | 0 | 0 | 0 | $0 |
| Timothy E Baxter | Direktor | 2. April 2026 A | 21.097 | 0 | 0 | $0 |
| Debra White | Direktor | 2. April 2026 A | 21.097 | 0 | 0 | $0 |
| Sundeep Agrawal | Direktor | 2. April 2026 A | 19.337 | 0 | 0 | $0 |
| Michael J Glennon | Direktor | 2. April 2026 A | 21.653 | 0 | 0 | $0 |
| Ronald M Sparks | Direktor | 2. April 2026 A | 21.097 | 0 | 0 | $0 |
| Joan B Harvey | Direktor | 22. Februar 2024 A | 65.000 | 0 | 0 | $0 |
| James L Cox | Direktor | 22. Februar 2024 A | 65.000 | 0 | 0 | $0 |
| David S. Battleman | Direktor | 1. April 2021 A | · | 0 | 0 | $0 |
| Joshua R Lamstein | Direktor | 21. Dezember 2017 J | 163.177 | 0 | 0 | $0 |
| Matthew Sirovich | 10%-Eigentümer | 25. November 2020 S | 1.027.744 | 0 | 0 | $0 |
| Ira Scott Greenspan | 10%-Eigentümer | 8. Juni 2018 S | 421.691 | 0 | 0 | $0 |
| Iv David Weild | · | 1. April 2021 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 2 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
PAVM Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 8 Analysten
KAUF
Median-Ziel
$36.50
+1171,8%
2 25,0%
Starker Kauf
5 62,5%
Kauf
1 12,5%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
2 Analysten · 2026-09-29Mittelwert-Ziel $36.50 +1171,8%
← Unter allen Zielen
Aktueller Preis $2.87
Tief$16.00
Mittelwert$36.50
Hoch$57.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 13, 2026